Knowledge

HLA-A11

Source đź“ť

48: 484:
It appears that these and other viruses have learned to exploit some defect in the region surrounding A11 that allows the near complete shut-down of gene expression. Oddly, in Africa A11 is at very low frequencies, and homozygotes are rare, suggesting that other genetic susceptibilities may exist
452:
infection. Examination of the virus itself has led to the discovery of strains that can all but turn off the A11-mediated class I response to the virus in A11 enriched peoples (see tables below). This ability to turn off the immune system and for the virus to remain active is a factor in
471:
down-regulation in Burkitt's lymphoma was subsequently discovered, More recent studies show A11 is down-regulated, and that other genetic defects are a likely cause. The ability to present EB virus antigens revealed a defect in the process after antigen process but before
435:
A11 is also part of a haplotype A11-Cw4-B35-DR1-DQ1 that is a second factor in the rapid progression of HIV. The involvement of non-Hodgkin's lymphoma primarily as a result of Epstein-Barr virus reinfection does not appear to be a cause in this acceleration.
476:
involvement. Other studies indicated that peptides bind A11 in delivery to the cell surface for CTL screening, but fall off, and are destroyed intracellularly. However, A3 and A11 can process and load antigens even when
431:
There is a strong association between anti-depressant induced hepatitis and HLA-A11. In autoimmune hepatitis, A11 has a synergistic effect, acting together with DR4 and DR3 to increase the odds of disease to over 300.
399:
Serotyping of A11 demonstrates better recognition of the *1101 gene products and poorer recognition of other A*11 gene products. There are ~40 recognized alleles of A*11. There is only one null classified as A11.
2165:
Marcos Y, Fainboim HA, Capucchio M, et al. (June 1994). "Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic active hepatitis".
2432:"Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma" 2567:"Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes" 1820:"T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues" 1783:
Arce-Gomez B, Jones EA, Barnstable CJ, Solomon E, Bodmer WF (February 1978). "The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin".
2130:
Berson A, FrĂ©neaux E, Larrey D, et al. (March 1994). "Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis".
297: "A" serotype group. The serotype is determined by the antibody recognition of α subset of HLA-A α-chains. For A11, the alpha "A" chain are encoded by the HLA-A 1885:
Gregoriadis S, Zervas J, Varletzidis E, Toubis M, Pantazopoulos P, Fessas P (December 1982). "HLA antigens and otosclerosis. A possible new genetic factor".
425: 2481:
Imreh MP, Zhang QJ, de Campos-Lima PO, et al. (July 1995). "Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma".
481:
activity is diminished suggesting an alternative mechanism for loading which may benefit in recovery from some disease but impair recovery of others.
424:. These and other studies suggest an involvement between A11 and secondary effects of certain herpes virus infections. A11 was also found increase in 2350:"Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease" 2642:"Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women" 20: 2542: 2525: 459:
and recent studies have shown a complex involvement of Epstein-Barr virus infection as a consequence of low A11 control over infection.
2068:
Konieczna A, Turowski G (1993). "HLA-ABC antigens in supraglottic cancer patients and their relationship with incidence and survival".
2699: 2603:
Middleton, D.; Menchaca, L.; Rood, H.; Komerofsky, R. (2003). "New allele frequency database: http://www.allelefrequencies.net".
2381:"Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines" 2252:"Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations" 2095:
Barona P, SierrasesĂşmaga L, AntillĂłn F, Villa-ElĂ­zaga I (1993). "Study of HLA antigens in patients with osteosarcoma".
1873: 275: 2025:
Iannetti P, Morellini M, Raucci U, Cappellacci S (1988). "HLA antigens, epilepsy and cytomegalovirus infection".
467:
eventually lead to the discovery of the virus, however this disease is more evident in Africa. An involvement in
2349: 2692: 312:
are almost synonymous in meaning. A11 is more common in East Asia than elsewhere, it is part of several long
1955:
Xu XP, Li SB, Wang CY, Li QH (June 1986). "Study on the association of HLA with pulmonary tuberculosis".
445: 2526:"Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells" 1990:
Kim SJ, Choi IH, Dahlberg S, Nisperos B, Kim JD, Hansen JA (March 1987). "HLA and leprosy in Koreans".
2605: 2566: 2685: 2202: 468: 287: 1920:
Singhal SK, Mann SB, Datta U, Panda NK, Gupta AK (1999). "Genetic correlation in otosclerosis".
2876: 449: 256: 242: 198: 160: 78: 1869: 463: 455: 271: 302: 111: 89: 8: 1898: 2506: 2276: 2251: 2232: 2050: 2003: 1844: 1819: 1796: 2407: 2380: 2325: 2300: 2267: 2143: 2038: 1933: 2663: 2622: 2618: 2578: 2547: 2498: 2463: 2458: 2431: 2412: 2379:
Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G (July 1987).
2361: 2330: 2281: 2224: 2183: 2179: 2147: 2112: 2077: 2042: 2007: 1972: 1937: 1902: 1849: 1800: 2510: 2430:
Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG (July 1992).
2653: 2614: 2537: 2490: 2453: 2443: 2402: 2392: 2320: 2312: 2271: 2263: 2236: 2214: 2175: 2139: 2104: 2054: 2034: 1999: 1964: 1929: 1894: 1839: 1831: 1792: 1721: 1633: 1569: 1329: 453:
carcinogenesis. Early studies of A serotypes revealed and association of A11 with
2524:
Frisan T, Zhang QJ, Levitskaya J, Coram M, Kurilla MG, Masucci MG (October 1996).
2301:"Analysis of HL-A antigens in patients with Hodgkin's disease and their families" 1737: 417: 102: 1741: 2640:
Chan D, Cheung T, Tam A, Cheung J, Yim S, Lo K, Siu N, Zhou D, Chan P (2005).
1968: 2870: 2565:
Levitsky V, Zhang QJ, Levitskaya J, Kurilla MG, Masucci MG (December 1997).
2448: 2397: 2219: 1866: 2667: 2626: 2543:
10.1002/(SICI)1097-0215(19961009)68:2<251::AID-IJC19>3.0.CO;2-D
2494: 2285: 1941: 1835: 409: 2582: 2551: 2502: 2467: 2416: 2365: 2334: 2228: 2187: 2151: 2116: 2081: 2046: 2011: 1976: 1906: 1853: 2094: 95: 34: 1804: 323: 478: 2378: 2316: 2108: 305: 185: 179: 173: 167: 54: 1652: 1588: 1348: 502: 313: 2711: 2658: 2641: 1818:
de Campos-Lima PO, Levitsky V, Brooks J, et al. (April 1994).
428:
with poor 3 year survival. In osteosarcoma A11 was found elevated.
421: 290: 52:
Rendering of A11 (A*1101-B2M) in complex with HBV peptide homologue
2677: 2024: 1884: 316:
that appear to have been frequent in the ancient peoples of Asia.
2855: 2850: 2843: 2838: 2833: 2826: 2821: 2816: 2811: 2806: 2801: 2796: 2784: 2779: 2774: 2769: 2764: 2759: 2752: 2747: 2429: 413: 73: 1782: 2742: 2737: 2732: 2727: 2602: 82: 2564: 2722: 2708: 294: 107: 38: 2348:
Dolcetti R, Frisan T, Sjöberg J, et al. (August 1995).
1817: 473: 2523: 47: 2250:
Chu PG, Chang KL, Chen WG, et al. (September 1999).
408:
Associations have been observed between A11 and familial
308:. This group currently is dominated by A*1101. A11 and A 2480: 2164: 1989: 2203:"Influence of host genes on HIV-1 disease progression" 2347: 1919: 2129: 2639: 2067: 2868: 485:that steer the virus toward Burkitt's lymphoma. 2598: 2596: 2594: 2592: 325:A11 recognition of some HLA A*11 gene products 2693: 1736:A*1104 is associated with increased risk for 439: 2589: 2298: 2249: 2243: 301:allele group and the β-chain are encoded by 62:-microglobulin (Rose), HBV peptide (yellow). 2558: 2517: 2474: 2423: 2372: 2341: 2292: 2194: 2158: 2123: 2088: 1913: 2700: 2686: 2061: 2018: 1983: 1954: 1948: 1878: 1811: 1759:A11-Cw9-B13 (Southern China & SE Asia) 46: 2657: 2541: 2457: 2447: 2406: 2396: 2324: 2275: 2218: 1843: 1776: 444:There are at least a couple of forms of 403: 2200: 1731: 58:​ HLA-A11 'alpha chain' (Cyan), β 2869: 2681: 448:that appear to arise from unresolved 1899:10.1001/archotol.1982.00790600013004 2707: 1747: 13: 2004:10.1111/j.1399-0039.1987.tb01567.x 1797:10.1111/j.1399-0039.1978.tb01233.x 14: 2888: 2299:Forbes JF, Morris PJ (May 1972). 1874:European Bioinformatics Institute 2619:10.1034/j.1399-0039.2003.00062.x 16:Human leukocyte antigen serotype 2633: 1860: 1: 2268:10.1016/S0002-9440(10)65193-0 2144:10.1016/S0168-8278(94)80004-9 2039:10.1016/s0387-7604(88)80008-1 1934:10.1016/S0196-0709(99)90019-4 1769: 2436:Proc. Natl. Acad. Sci. U.S.A 2385:Proc. Natl. Acad. Sci. U.S.A 2180:10.1016/0270-9139(94)90230-5 446:lymphoproliferative diseases 7: 319: 10: 2893: 1765:A11-CBL-B13 Northern China 1708:China Beijing Shijiazhuan… 1700:Israel Ashkenazi and Non … 1620:China Beijing Shijiazhuan… 1492:China Beijing Shijiazhuan… 1316:Morocco Berber Nador Meta… 1228:Spain Basque Gipuzkoa Pro… 948:Sri Lanka Colombo Sinhale… 892:India Andhra Pradesh Goll… 820:Singapore Javanese Indone… 796:Spain Basque Arratia Vall… 732:Australia Indig. Cape Yor… 716:China, Shandong, Linqu Co… 676:Australia Indig. Groote E… 652:Taiwanese of Middle China… 488: 440:Epstein–Barr virus anomaly 412:, pulmonary tuberculosis, 18: 2718: 1969:10.3109/08820138609052951 1719: 1715: 1707: 1699: 1691: 1683: 1675: 1667: 1663: 1648: 1631: 1627: 1619: 1611: 1603: 1599: 1584: 1567: 1563: 1555: 1547: 1539: 1531: 1523: 1515: 1507: 1499: 1491: 1483: 1475: 1467: 1459: 1451: 1443: 1435: 1428:Ch. Guangdong Meizhou Han 1427: 1419: 1411: 1403: 1395: 1387: 1379: 1371: 1363: 1359: 1344: 1327: 1323: 1315: 1307: 1299: 1291: 1283: 1275: 1267: 1259: 1251: 1243: 1235: 1227: 1219: 1211: 1203: 1196:Georgia Tbilisi Georgian… 1195: 1187: 1179: 1171: 1163: 1156:Australia New South Wales 1155: 1147: 1139: 1131: 1123: 1115: 1107: 1099: 1092:Australia Indig. Yuendumu 1091: 1083: 1075: 1067: 1059: 1051: 1043: 1035: 1027: 1019: 1011: 1003: 995: 987: 979: 972:Australia Indig. Kimberly 971: 963: 955: 947: 939: 931: 923: 915: 907: 899: 891: 883: 875: 867: 859: 851: 843: 835: 827: 819: 811: 803: 795: 787: 779: 771: 763: 755: 747: 739: 731: 723: 715: 707: 699: 691: 683: 675: 667: 659: 651: 643: 635: 627: 619: 611: 603: 595: 587: 579: 571: 563: 555: 547: 536: 517: 513: 498: 269: 251: 237: 232:Available structures 220: 216: 211: 193: 155: 150:Available structures 138: 134: 129: 121: 101: 88: 72: 67: 45: 32: 27: 940:Mongolia Khoton Tarialan 2449:10.1073/pnas.89.13.5862 2398:10.1073/pnas.84.13.4567 2220:10.1096/fasebj.12.9.625 1524:India West Coast Parsis 469:cytotoxic T-lymphocytes 288:human leukocyte antigen 21:HLA serotypes explained 2495:10.1002/ijc.2910620117 1836:10.1084/jem.179.4.1297 1644:HLA A*1104 frequencies 1580:HLA A*1103 frequencies 1340:HLA A*1102 frequencies 1140:USA Caucasian Bethesda 1020:Spain North Cantabrian 996:Spain North Cabuernigo 884:China Harbin N. Korean 660:PNG New Britain Rabaul 494:HLA A*1101 frequencies 79:transmembrane receptor 2201:Roger M (June 1998). 1740:resulting from human 1668:Georgia Svaneti Svans 956:Georgia Tbilisi Kurds 876:India Mumbai Marathas 844:Georgia Svaneti Svans 812:Russia Murmansk Saomi 404:In infectious disease 41:cell surface antigen) 19:Further information: 1732:Disease associations 1676:Singapore Riau Malay 1516:China Inner Mongolia 1404:China Guangxi Maonan 868:China Yunnan Han (2) 780:China Inner Mongolia 748:Singapore Riau Malay 580:China Guangxi Maonan 540:West Schrader Ranges 270:Alleles link-out to 1645: 1581: 1341: 1252:Portugal South pop2 1148:Portugal Centre (2) 740:PNG Karimui Plateau 495: 426:supraglottic cancer 326: 1738:cervical neoplasia 1722:Allele frequencies 1692:India North Hindus 1643: 1634:Allele frequencies 1579: 1570:Allele frequencies 1420:Philippines Ivatan 1339: 1330:Allele frequencies 1172:USA Hawaii Okinawa 1132:Philippines Ivatan 1108:USA Caucasians (3) 1084:Italy Sardinia (3) 852:India North Hindus 636:Thailand Northeast 493: 464:Burkitt's lymphoma 456:Hodgkin's lymphoma 450:Epstein–Barr virus 324: 2864: 2863: 2317:10.1172/JCI106908 2109:10.1159/000154149 1867:Allele Query Form 1729: 1728: 1725: 1659: 1641: 1640: 1637: 1604:China Yunnan Lisu 1595: 1577: 1576: 1573: 1548:China Yunnan Lisu 1540:China Qinghai Hui 1500:Italy North pop 1 1468:Singapore Chinese 1452:Taiwan Minnan (1) 1444:Hong Kong Chinese 1355: 1337: 1336: 1333: 1268:Italy North Pavia 1260:England Newcastle 980:India North Delhi 916:Israel Arab Druse 804:China Qinghai Hui 644:Singapore Chinese 596:Taiwan Minnan (1) 509: 397: 396: 281: 280: 265: 264: 207: 206: 2884: 2702: 2695: 2688: 2679: 2678: 2672: 2671: 2661: 2637: 2631: 2630: 2600: 2587: 2586: 2562: 2556: 2555: 2545: 2521: 2515: 2514: 2478: 2472: 2471: 2461: 2451: 2427: 2421: 2420: 2410: 2400: 2376: 2370: 2369: 2345: 2339: 2338: 2328: 2296: 2290: 2289: 2279: 2247: 2241: 2240: 2222: 2198: 2192: 2191: 2162: 2156: 2155: 2127: 2121: 2120: 2092: 2086: 2085: 2065: 2059: 2058: 2022: 2016: 2015: 1987: 1981: 1980: 1952: 1946: 1945: 1922:Am J Otolaryngol 1917: 1911: 1910: 1887:Arch Otolaryngol 1882: 1876: 1864: 1858: 1857: 1847: 1815: 1809: 1808: 1780: 1762:A11-C10-B13 Buyi 1756:A11-Cw2-B13 (Li) 1748:A11-B haplotypes 1720: 1657: 1649:Study population 1646: 1642: 1632: 1593: 1585:Study population 1582: 1578: 1568: 1353: 1345:Study population 1342: 1338: 1328: 1284:Sweden Stockholm 1244:Russia Northwest 1100:Mongolia Tsaatan 1052:Ireland Northern 964:Mongolia Khalkha 860:Pakistan Burusho 564:ChinaYunnan Naxi 507: 499:Study population 496: 492: 327: 311: 300: 259: 245: 218: 217: 201: 188: 182: 176: 170: 163: 136: 135: 57: 50: 25: 24: 2892: 2891: 2887: 2886: 2885: 2883: 2882: 2881: 2867: 2866: 2865: 2860: 2714: 2706: 2676: 2675: 2652:(10): 1749–56. 2638: 2634: 2606:Tissue Antigens 2601: 2590: 2577:(11): 5383–90. 2563: 2559: 2522: 2518: 2479: 2475: 2428: 2424: 2391:(13): 4567–71. 2377: 2373: 2360:(16): 3675–81. 2346: 2342: 2305:J. Clin. Invest 2297: 2293: 2248: 2244: 2199: 2195: 2163: 2159: 2128: 2124: 2093: 2089: 2066: 2062: 2023: 2019: 1992:Tissue Antigens 1988: 1984: 1957:Immunol. Invest 1953: 1949: 1918: 1914: 1883: 1879: 1865: 1861: 1830:(4): 1297–305. 1816: 1812: 1785:Tissue Antigens 1781: 1777: 1772: 1750: 1734: 1724:presented, only 1655: 1636:presented, only 1612:China Yunnan Nu 1591: 1572:presented, only 1351: 1332:presented, only 1076:Italy North (1) 1012:Russia Tuva (2) 924:South Korea (3) 772:Pakistan Pathan 724:Pakistan Sindhi 700:Pakistan Baloch 684:India New Delhi 668:Pakistan Brahui 628:China South Han 588:China Guangzhou 505: 491: 442: 420:infection with 418:cytomegalovirus 406: 322: 309: 298: 255: 241: 233: 228: 223: 197: 184: 178: 172: 166: 159: 151: 146: 141: 115: 63: 61: 53: 23: 17: 12: 11: 5: 2890: 2880: 2879: 2862: 2861: 2859: 2858: 2853: 2848: 2847: 2846: 2841: 2831: 2830: 2829: 2824: 2819: 2814: 2809: 2804: 2794: 2789: 2788: 2787: 2782: 2777: 2772: 2767: 2757: 2756: 2755: 2750: 2740: 2735: 2730: 2725: 2719: 2716: 2715: 2705: 2704: 2697: 2690: 2682: 2674: 2673: 2659:10.1086/497342 2632: 2613:(5): 403–407. 2588: 2557: 2530:Int. J. Cancer 2516: 2483:Int. J. Cancer 2473: 2442:(13): 5862–6. 2422: 2371: 2340: 2311:(5): 1156–63. 2291: 2242: 2193: 2157: 2122: 2087: 2060: 2017: 1982: 1947: 1912: 1893:(12): 769–71. 1877: 1859: 1810: 1774: 1773: 1771: 1768: 1767: 1766: 1763: 1760: 1757: 1749: 1746: 1742:papillomavirus 1733: 1730: 1727: 1726: 1717: 1716: 1713: 1712: 1709: 1705: 1704: 1701: 1697: 1696: 1693: 1689: 1688: 1685: 1684:American Samoa 1681: 1680: 1677: 1673: 1672: 1669: 1665: 1664: 1661: 1660: 1650: 1639: 1638: 1629: 1628: 1625: 1624: 1621: 1617: 1616: 1613: 1609: 1608: 1605: 1601: 1600: 1597: 1596: 1586: 1575: 1574: 1565: 1564: 1561: 1560: 1557: 1553: 1552: 1549: 1545: 1544: 1541: 1537: 1536: 1533: 1529: 1528: 1525: 1521: 1520: 1517: 1513: 1512: 1509: 1505: 1504: 1501: 1497: 1496: 1493: 1489: 1488: 1485: 1481: 1480: 1477: 1473: 1472: 1469: 1465: 1464: 1461: 1457: 1456: 1453: 1449: 1448: 1445: 1441: 1440: 1437: 1433: 1432: 1429: 1425: 1424: 1421: 1417: 1416: 1413: 1409: 1408: 1405: 1401: 1400: 1397: 1393: 1392: 1389: 1385: 1384: 1381: 1377: 1376: 1373: 1369: 1368: 1365: 1364:Taiwan Saisiat 1361: 1360: 1357: 1356: 1346: 1335: 1334: 1325: 1324: 1321: 1320: 1317: 1313: 1312: 1309: 1305: 1304: 1301: 1297: 1296: 1293: 1289: 1288: 1285: 1281: 1280: 1277: 1273: 1272: 1269: 1265: 1264: 1261: 1257: 1256: 1253: 1249: 1248: 1245: 1241: 1240: 1237: 1233: 1232: 1229: 1225: 1224: 1221: 1217: 1216: 1213: 1209: 1208: 1205: 1201: 1200: 1197: 1193: 1192: 1189: 1185: 1184: 1181: 1177: 1176: 1173: 1169: 1168: 1165: 1161: 1160: 1157: 1153: 1152: 1149: 1145: 1144: 1141: 1137: 1136: 1133: 1129: 1128: 1125: 1121: 1120: 1117: 1113: 1112: 1109: 1105: 1104: 1101: 1097: 1096: 1093: 1089: 1088: 1085: 1081: 1080: 1077: 1073: 1072: 1069: 1065: 1064: 1061: 1057: 1056: 1053: 1049: 1048: 1045: 1041: 1040: 1037: 1033: 1032: 1029: 1025: 1024: 1021: 1017: 1016: 1013: 1009: 1008: 1005: 1001: 1000: 997: 993: 992: 989: 985: 984: 981: 977: 976: 973: 969: 968: 965: 961: 960: 957: 953: 952: 949: 945: 944: 941: 937: 936: 933: 929: 928: 925: 921: 920: 917: 913: 912: 909: 905: 904: 901: 900:Taiwan Saisiat 897: 896: 893: 889: 888: 885: 881: 880: 877: 873: 872: 869: 865: 864: 861: 857: 856: 853: 849: 848: 845: 841: 840: 837: 833: 832: 829: 825: 824: 821: 817: 816: 813: 809: 808: 805: 801: 800: 797: 793: 792: 789: 788:American Samoa 785: 784: 781: 777: 776: 773: 769: 768: 765: 761: 760: 757: 753: 752: 749: 745: 744: 741: 737: 736: 733: 729: 728: 725: 721: 720: 717: 713: 712: 709: 705: 704: 701: 697: 696: 693: 689: 688: 685: 681: 680: 677: 673: 672: 669: 665: 664: 661: 657: 656: 653: 649: 648: 645: 641: 640: 637: 633: 632: 629: 625: 624: 621: 617: 616: 613: 609: 608: 605: 601: 600: 597: 593: 592: 589: 585: 584: 581: 577: 576: 573: 569: 568: 565: 561: 560: 557: 553: 552: 549: 545: 544: 541: 534: 533: 530: 515: 514: 511: 510: 500: 490: 487: 441: 438: 405: 402: 395: 394: 391: 388: 384: 383: 380: 377: 373: 372: 369: 366: 362: 361: 358: 355: 351: 350: 347: 344: 340: 339: 336: 331: 321: 318: 279: 278: 267: 266: 263: 262: 260: 253: 249: 248: 246: 239: 235: 234: 231: 229: 226: 224: 221: 214: 213: 209: 208: 205: 204: 202: 195: 191: 190: 164: 157: 153: 152: 149: 147: 144: 142: 139: 132: 131: 127: 126: 123: 119: 118: 116:-microglobulin 113: 105: 99: 98: 92: 86: 85: 76: 70: 69: 65: 64: 59: 51: 43: 42: 30: 29: 15: 9: 6: 4: 3: 2: 2889: 2878: 2877:HLA-A alleles 2875: 2874: 2872: 2857: 2854: 2852: 2849: 2845: 2842: 2840: 2837: 2836: 2835: 2832: 2828: 2825: 2823: 2820: 2818: 2815: 2813: 2810: 2808: 2805: 2803: 2800: 2799: 2798: 2795: 2793: 2790: 2786: 2783: 2781: 2778: 2776: 2773: 2771: 2768: 2766: 2763: 2762: 2761: 2758: 2754: 2751: 2749: 2746: 2745: 2744: 2741: 2739: 2736: 2734: 2731: 2729: 2726: 2724: 2721: 2720: 2717: 2713: 2710: 2703: 2698: 2696: 2691: 2689: 2684: 2683: 2680: 2669: 2665: 2660: 2655: 2651: 2647: 2643: 2636: 2628: 2624: 2620: 2616: 2612: 2608: 2607: 2599: 2597: 2595: 2593: 2584: 2580: 2576: 2572: 2568: 2561: 2553: 2549: 2544: 2539: 2535: 2531: 2527: 2520: 2512: 2508: 2504: 2500: 2496: 2492: 2488: 2484: 2477: 2469: 2465: 2460: 2455: 2450: 2445: 2441: 2437: 2433: 2426: 2418: 2414: 2409: 2404: 2399: 2394: 2390: 2386: 2382: 2375: 2367: 2363: 2359: 2355: 2351: 2344: 2336: 2332: 2327: 2322: 2318: 2314: 2310: 2306: 2302: 2295: 2287: 2283: 2278: 2273: 2269: 2265: 2261: 2257: 2256:Am. J. Pathol 2253: 2246: 2238: 2234: 2230: 2226: 2221: 2216: 2213:(9): 625–32. 2212: 2208: 2204: 2197: 2189: 2185: 2181: 2177: 2174:(6): 1371–4. 2173: 2169: 2161: 2153: 2149: 2145: 2141: 2138:(3): 336–42. 2137: 2133: 2126: 2118: 2114: 2110: 2106: 2102: 2098: 2091: 2083: 2079: 2075: 2071: 2070:Mater Med Pol 2064: 2056: 2052: 2048: 2044: 2040: 2036: 2032: 2028: 2021: 2013: 2009: 2005: 2001: 1998:(3): 146–53. 1997: 1993: 1986: 1978: 1974: 1970: 1966: 1963:(4): 327–32. 1962: 1958: 1951: 1943: 1939: 1935: 1931: 1927: 1923: 1916: 1908: 1904: 1900: 1896: 1892: 1888: 1881: 1875: 1871: 1868: 1863: 1855: 1851: 1846: 1841: 1837: 1833: 1829: 1825: 1821: 1814: 1806: 1802: 1798: 1794: 1791:(2): 96–112. 1790: 1786: 1779: 1775: 1764: 1761: 1758: 1755: 1754: 1753: 1745: 1743: 1739: 1723: 1718: 1714: 1710: 1706: 1702: 1698: 1694: 1690: 1686: 1682: 1678: 1674: 1670: 1666: 1662: 1654: 1651: 1647: 1635: 1630: 1626: 1622: 1618: 1614: 1610: 1606: 1602: 1598: 1590: 1587: 1583: 1571: 1566: 1562: 1558: 1554: 1550: 1546: 1542: 1538: 1534: 1530: 1526: 1522: 1518: 1514: 1510: 1508:Taiwan Taroko 1506: 1502: 1498: 1494: 1490: 1486: 1482: 1478: 1474: 1470: 1466: 1462: 1458: 1454: 1450: 1446: 1442: 1438: 1434: 1430: 1426: 1422: 1418: 1414: 1412:Taiwan Atayal 1410: 1406: 1402: 1398: 1396:Taiwan Siraya 1394: 1390: 1388:Taiwan Puyuma 1386: 1382: 1378: 1374: 1370: 1366: 1362: 1358: 1350: 1347: 1343: 1331: 1326: 1322: 1318: 1314: 1310: 1308:Italy Bergamo 1306: 1302: 1300:Macedonia (4) 1298: 1294: 1290: 1286: 1282: 1278: 1274: 1270: 1266: 1262: 1258: 1254: 1250: 1246: 1242: 1238: 1234: 1230: 1226: 1222: 1218: 1214: 1210: 1206: 1204:Ireland South 1202: 1198: 1194: 1190: 1186: 1182: 1178: 1174: 1170: 1166: 1162: 1158: 1154: 1150: 1146: 1142: 1138: 1134: 1130: 1126: 1124:Taiwan Taroko 1122: 1118: 1114: 1110: 1106: 1102: 1098: 1094: 1090: 1086: 1082: 1078: 1074: 1070: 1066: 1062: 1060:Taiwan Atayal 1058: 1054: 1050: 1046: 1042: 1038: 1034: 1030: 1028:Japan Central 1026: 1022: 1018: 1014: 1010: 1006: 1002: 998: 994: 990: 986: 982: 978: 974: 970: 966: 962: 958: 954: 950: 946: 942: 938: 934: 930: 926: 922: 918: 914: 910: 906: 902: 898: 894: 890: 886: 882: 878: 874: 870: 866: 862: 858: 854: 850: 846: 842: 838: 834: 830: 828:New Caledonia 826: 822: 818: 814: 810: 806: 802: 798: 794: 790: 786: 782: 778: 774: 770: 766: 764:China Beijing 762: 758: 756:Taiwan Siraya 754: 750: 746: 742: 738: 734: 730: 726: 722: 718: 714: 710: 706: 702: 698: 694: 690: 686: 682: 678: 674: 670: 666: 662: 658: 654: 650: 646: 642: 638: 634: 630: 626: 622: 618: 614: 610: 606: 602: 598: 594: 590: 586: 582: 578: 574: 570: 566: 562: 558: 554: 550: 546: 542: 539: 535: 531: 528: 524: 520: 516: 512: 504: 501: 497: 486: 482: 480: 475: 470: 466: 465: 460: 458: 457: 451: 447: 437: 433: 429: 427: 423: 419: 415: 411: 401: 392: 389: 386: 385: 381: 378: 375: 374: 370: 367: 364: 363: 359: 356: 353: 352: 348: 345: 342: 341: 337: 335: 332: 329: 328: 317: 315: 307: 304: 296: 292: 289: 285: 277: 273: 268: 261: 258: 254: 250: 247: 244: 240: 236: 230: 225: 219: 215: 210: 203: 200: 196: 192: 187: 181: 175: 169: 165: 162: 158: 154: 148: 143: 137: 133: 128: 124: 120: 117: 109: 106: 104: 100: 97: 93: 91: 87: 84: 80: 77: 75: 71: 66: 56: 49: 44: 40: 36: 31: 26: 22: 2791: 2649: 2646:J Infect Dis 2645: 2635: 2610: 2604: 2574: 2570: 2560: 2536:(2): 251–8. 2533: 2529: 2519: 2486: 2482: 2476: 2439: 2435: 2425: 2388: 2384: 2374: 2357: 2353: 2343: 2308: 2304: 2294: 2262:(3): 941–7. 2259: 2255: 2245: 2210: 2206: 2196: 2171: 2167: 2160: 2135: 2131: 2125: 2103:(5): 311–4. 2100: 2096: 2090: 2073: 2069: 2063: 2033:(4): 256–8. 2030: 2026: 2020: 1995: 1991: 1985: 1960: 1956: 1950: 1928:(2): 102–5. 1925: 1921: 1915: 1890: 1886: 1880: 1862: 1827: 1823: 1813: 1788: 1784: 1778: 1751: 1735: 1532:Taiwan Bunun 1436:Taiwan Hakka 1372:Taiwan Pazeh 1276:Israeli Jews 1068:Jordan Amman 1044:Greece North 1004:Saudi Arabia 620:Taiwan Pazeh 548:Taiwan Hakka 537: 529:uinea Madang 526: 522: 518: 483: 462: 461: 454: 443: 434: 430: 410:otosclerosis 407: 398: 333: 283: 282: 274:database at 212:Rare alleles 2489:(1): 90–6. 2076:(2): 73–9. 1824:J. Exp. Med 1658:(in %) 1594:(in %) 1484:Taiwan Tsou 1354:(in %) 988:Japan Hyogo 932:Taiwan Tsou 836:Japan Aichi 708:Taiwan Thao 612:China Wuhan 508:(in %) 286:(A11) is a 194:A11K, A11.2 156:A11E, A11.1 122:Older names 96:heterodimer 35:MHC Class I 2571:J. Immunol 2354:Cancer Res 2168:Hepatology 2132:J. Hepatol 2097:Hum. Hered 1770:References 1744:infection 1476:Taiwan Tao 1380:Taiwan Ami 1236:Turkey (2) 1212:Algeria(1) 572:Taiwan Tao 556:PNG Wosera 479:proteosome 314:haplotypes 2712:serotypes 2027:Brain Dev 1556:Japan (3) 692:USA Asian 349:size (N) 183:​, 177:​, 171:​, 90:Structure 2871:Category 2668:16235173 2627:12753660 2511:25993298 2286:10487851 1942:10203160 1870:IMGT/HLA 1752:A11-B13 1460:Thailand 1116:Bulgaria 1036:Romanian 604:Thailand 422:epilepsy 320:Serotype 291:serotype 272:IMGT/HLA 130:Subtypes 103:Subunits 2583:9548478 2552:8900437 2503:7601573 2468:1321426 2417:3037521 2366:7627978 2335:5020429 2277:1866909 2237:7210509 2229:9619442 2207:FASEB J 2188:8188167 2152:8014443 2117:8406520 2082:8072312 2055:4706944 2047:2851270 2012:3603547 1977:3759149 1907:6983341 1854:7511684 1845:2191457 1292:Finland 1164:Morocco 489:Alleles 414:leprosy 338:Sample 293:within 284:HLA-A11 222:Subtype 189:​ 140:Subtype 110:*11--, 74:Protein 28:HLA-A11 2666:  2625:  2581:  2550:  2509:  2501:  2466:  2456:  2415:  2408:305131 2405:  2364:  2333:  2326:292245 2323:  2284:  2274:  2235:  2227:  2186:  2150:  2115:  2080:  2053:  2045:  2010:  1975:  1940:  1905:  1852:  1842:  1803:  1656:  1592:  1352:  1220:Brazil 1188:Serbia 506:  416:, and 343:allele 227:allele 145:allele 125:HL-A11 83:ligand 2723:HLA-A 2709:HLA-A 2507:S2CID 2459:49397 2233:S2CID 2051:S2CID 1805:77067 1653:Freq. 1589:Freq. 1349:Freq. 1180:Wales 521:apua 503:Freq. 387:*1104 376:*1103 365:*1102 360:2530 354:*1101 330:A*11 306:locus 295:HLA-A 257:*1104 252:A11.4 243:*1103 238:A11.3 199:*1102 161:*1101 108:HLA-A 68:About 2664:PMID 2623:PMID 2579:PMID 2548:PMID 2499:PMID 2464:PMID 2413:PMID 2362:PMID 2331:PMID 2282:PMID 2225:PMID 2184:PMID 2148:PMID 2113:PMID 2078:PMID 2043:PMID 2008:PMID 1973:PMID 1938:PMID 1903:PMID 1850:PMID 1801:PMID 1375:10.9 1367:12.7 967:10.0 959:10.0 951:10.4 943:10.7 935:10.8 927:10.8 919:11.0 911:11.4 908:Oman 903:11.8 895:11.9 887:12.1 879:12.3 871:12.3 863:12.5 855:12.5 847:12.5 839:12.7 831:13.1 823:14.0 815:14.0 807:15.9 799:16.0 791:16.0 783:16.2 775:16.3 767:16.4 759:17.6 751:17.7 743:17.9 735:18.0 727:19.6 719:20.4 711:21.7 703:22.2 695:23.0 687:23.5 679:24.0 671:25.2 663:26.0 655:26.2 647:26.5 639:27.1 631:27.7 623:28.2 615:29.3 607:29.9 599:30.9 591:33.8 583:35.2 575:36.0 567:38.0 559:38.5 551:40.0 543:55.0 532:63.6 474:TAP1 186:1q94 180:1qvo 174:1x7q 168:2hn7 55:2HN7 2856:A80 2851:A36 2844:A69 2839:A68 2834:A28 2827:A74 2822:A33 2817:A32 2812:A31 2807:A30 2802:A29 2797:A19 2792:A11 2785:A66 2780:A43 2775:A34 2770:A26 2765:A25 2760:A10 2753:A24 2748:A23 2654:doi 2650:192 2615:doi 2575:159 2538:doi 2491:doi 2454:PMC 2444:doi 2403:PMC 2393:doi 2321:PMC 2313:doi 2272:PMC 2264:doi 2260:155 2215:doi 2176:doi 2140:doi 2105:doi 2035:doi 2000:doi 1965:doi 1930:doi 1895:doi 1891:108 1840:PMC 1832:doi 1828:179 1793:doi 1711:0.2 1703:0.4 1695:1.0 1687:1.0 1679:1.2 1671:1.3 1623:0.2 1615:3.8 1607:5.1 1559:0.2 1551:0.6 1543:0.9 1535:1.0 1527:1.0 1519:1.0 1511:1.8 1503:1.9 1495:2.0 1487:2.9 1479:3.0 1471:3.0 1463:3.5 1455:3.9 1447:4.0 1439:4.5 1431:4.6 1423:5.0 1415:5.2 1407:6.5 1399:6.9 1391:7.0 1383:8.7 1319:4.8 1311:4.8 1303:4.9 1295:5.0 1287:5.1 1279:5.4 1271:5.6 1263:5.7 1255:5.9 1247:6.0 1239:6.1 1231:6.1 1223:6.1 1215:6.2 1207:6.2 1199:6.2 1191:6.5 1183:6.6 1175:6.7 1167:6.7 1159:6.7 1151:6.8 1143:7.0 1135:7.0 1127:7.3 1119:7.3 1111:7.4 1103:7.6 1095:7.6 1087:7.7 1079:7.7 1071:7.9 1063:8.0 1055:8.0 1047:8.0 1039:8.2 1031:8.2 1023:8.4 1015:8.7 1007:8.7 999:8.9 991:9.4 983:9.4 975:9.7 538:PNG 525:ew 382:18 371:42 334:A11 310:*11 303:B2M 299:*11 276:EBI 94:αβ 2873:: 2743:A9 2738:A3 2733:A2 2728:A1 2662:. 2648:. 2644:. 2621:. 2611:61 2609:. 2591:^ 2573:. 2569:. 2546:. 2534:68 2532:. 2528:. 2505:. 2497:. 2487:62 2485:. 2462:. 2452:. 2440:89 2438:. 2434:. 2411:. 2401:. 2389:84 2387:. 2383:. 2358:55 2356:. 2352:. 2329:. 2319:. 2309:51 2307:. 2303:. 2280:. 2270:. 2258:. 2254:. 2231:. 2223:. 2211:12 2209:. 2205:. 2182:. 2172:19 2170:. 2146:. 2136:20 2134:. 2111:. 2101:43 2099:. 2074:25 2072:. 2049:. 2041:. 2031:10 2029:. 2006:. 1996:29 1994:. 1971:. 1961:15 1959:. 1936:. 1926:20 1924:. 1901:. 1889:. 1872:- 1848:. 1838:. 1826:. 1822:. 1799:. 1789:11 1787:. 393:6 390:60 379:83 368:76 357:99 346:% 37:, 2701:e 2694:t 2687:v 2670:. 2656:: 2629:. 2617:: 2585:. 2554:. 2540:: 2513:. 2493:: 2470:. 2446:: 2419:. 2395:: 2368:. 2337:. 2315:: 2288:. 2266:: 2239:. 2217:: 2190:. 2178:: 2154:. 2142:: 2119:. 2107:: 2084:. 2057:. 2037:: 2014:. 2002:: 1979:. 1967:: 1944:. 1932:: 1909:. 1897:: 1856:. 1834:: 1807:. 1795:: 527:G 523:N 519:P 114:2 112:β 81:/ 60:2 39:A 33:(

Index

HLA serotypes explained
MHC Class I
A

2HN7
Protein
transmembrane receptor
ligand
Structure
heterodimer
Subunits
HLA-A
β2-microglobulin
*1101
2hn7
1x7q
1qvo
1q94
*1102
*1103
*1104
IMGT/HLA
EBI
human leukocyte antigen
serotype
HLA-A
B2M
locus
haplotypes
otosclerosis

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑